Wyeth secures Australian injunction against MSD vaccine
30-11-2020
MSD secures victory before English court
20-10-2020
Appeals court sides with Pfizer, Merck KGaA in $5bn suit
29-09-2020
Katherine Welles / Shutterstock.com
In a mixed decision for Merck Sharp Dohme (MSD), the Federal Court of Australia has concluded that the pharmaceutical company is infringing one patent owned by Wyeth, but that two other Wyeth patents are invalid.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
MSD, Merck Sharp Dohme, Wyeth, Pfizer, vaccine, patent infringement, patent invalidity
